- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Exhibit 32.1
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Intra-Cellular Therapies, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2016 (the “Form10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: March 1, 2018 | /s/ Sharon Mates, Ph.D. | |||
Sharon Mates, Ph.D. | ||||
Chairman, President and Chief Executive Officer (principal executive officer) | ||||
Dated: March 1, 2018 | /s/ Lawrence J. Hineline | |||
Lawrence J. Hineline | ||||
Vice President of Finance and Chief Financial Officer (principal financial officer and principal accounting officer) |